← Eichor
Condition: Thromboembolic Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Thromboembolic Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
Phase N/A · 14 location(s) · University of Calgary · NCT05756244
Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
NA · 20 location(s) · University Hospital, Brest · NCT06731244
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Phase N/A · 1 location(s) · Chinese Pulmonary Vascular Disease Research Group · NCT02061787
Heat Shock Protein 47 in Thrombosis
Phase N/A · 2 location(s) · University of Aarhus · NCT06731673
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
Phase 3 · 4 location(s) · Ottawa Hospital Research Institute · NCT06440694
Caprini Score in Venous Surgery: a Prospective Cohort Study
Phase N/A · 1 location(s) · Pirogov Russian National Research Medical University · NCT03041805
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
NA · 22 location(s) · Beijing Anzhen Hospital · NCT06871228
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT07399977
Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07453017
LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04628078
Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06551415
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551
Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06958588
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Database in China
Phase N/A · 1 location(s) · China-Japan Friendship Hospital · NCT05311072
Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06531122
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
Phase N/A · 8 location(s) · University Hospital, Brest · NCT03206372
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Phase 3 · 7 location(s) · Ottawa Hospital Research Institute · NCT06393868
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Phase 4 · 1 location(s) · University of Aarhus · NCT07160504
Venous Thromboembolism Prevention in Outpatients With Glioma
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT05683808
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
Phase N/A · 2 location(s) · University Hospital, Clermont-Ferrand · NCT06575309
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replac
Phase 4 · 16 location(s) · Joon Bum Kim · NCT04258488
Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
Phase 3 · 8 location(s) · Marc Blondon · NCT07140211
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NA · 1 location(s) · University of Arkansas · NCT05301348
Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04660747
A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter
NA · 3 location(s) · LeMaitre Vascular · NCT05386277
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
EARLY_Phase 1 · 12 location(s) · China National Center for Cardiovascular Diseases · NCT06615596
Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation
Phase N/A · 4 location(s) · Saint Antoine University Hospital · NCT02741349
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
NA · 10 location(s) · University Hospital, Angers · NCT07499661
Early Detection of CTEPH in Patients After APE
Phase N/A · 10 location(s) · Institute of Health Information and Statistics of the Czech · NCT06865326
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis
NA · 3 location(s) · Imperial College London · NCT06166537
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.